The firm saw growth in its core laboratory segment but declines in molecular, point of care, and rapid diagnostics.

The agency said that the test is unnecessary for the screening of whole blood and blood components that are screened with nucleic acid tests and core antigen tests.

NEW YORK – Phase Scientific said Wednesday that has signed an exclusive US distribution agreement with Lumos Diagnostics for a 10-minute point-of-care blood test to distinguish bacterial and ...

The US Food and Drug Administration granted clearances for infectious disease tests, digital pathology software, and hematology analyzers, among other in vitro diagnostic technologies.

Agilent Technologies said that Robert McMahon will resign from as the company's senior vice president and chief financial officer, effective July 31 for family reasons. Rodney Gonsalves, Agilent's ...

The company's next-generation sequencing-based test is used to aid the detection of cancers in patients with indeterminate ...

The Determine Antenatal Care Panel is used for the simultaneous detection of infectious diseases that threaten maternal and pediatric health.

The partnership will initially focus on low-abundance biomarkers supporting translational research in Alzheimer's disease.